Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2005 Jan-Feb;4(1):64-70.

A multicenter clinical evaluation of the treatment of mild to moderate inflammatory acne vulgaris of the face with visible blue light in comparison to topical 1% clindamycin antibiotic solution

Michael H Gold  1 , Jaggi Rao, Mitchel P Goldman, Tancy M Bridges, Virginia L Bradshaw, Molly M Boring, April N Guider
Affiliations
  • PMID: 15696987
Clinical Trial

A multicenter clinical evaluation of the treatment of mild to moderate inflammatory acne vulgaris of the face with visible blue light in comparison to topical 1% clindamycin antibiotic solution

Michael H Gold et al. J Drugs Dermatol. 2005 Jan-Feb.

Abstract

Background: Blue light sources have been shown to be effective in the treatment of mild to moderate inflammatory acne vulgaris lesions.

Objective: We evaluated the safety and efficacy of a new blue light source in the treatment of mild to moderate inflammatory acne vulgaris in comparison to topical 1% clindamycin solution.

Results: Blue light therapy reduced inflammatory acne vulgaris lesions by an average of 34%, as compared to 14% for topical 1% clindamycin solution.

Conclusions: The blue light source presented in this report is a safe and effective treatment option available to our patients with mild to moderate inflammatory acne lesions.

PubMed Disclaimer

LinkOut - more resources